SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 117.81 |
| Enterprise Value ($M) | 84.59 |
| Book Value ($M) | 171.81 |
| Book Value / Share | 2.68 |
| Price / Book | 0.69 |
| NCAV ($M) | 166.89 |
| NCAV / Share | 2.61 |
| Price / NCAV | 0.71 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.46 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | -0.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.02 |
| Current Ratio | 8.02 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 195.30 |
| Assets | 200.22 |
| Liabilities | 28.41 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -90.89 |
| Net Income | -80.60 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -70.76 |
| Cash from Investing | -85.39 |
| Cash from Financing | 161.88 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Opaleye Management Inc. | 6.17 | 153.36 | |
| 13G | BlackRock, Inc. | 5.10 | 192.53 | |
| 13G/A | Janus Henderson Group Plc | 10.10 | 15.74 | |
| 13G/A | Verition Fund Management LLC | 0.90 | -78.87 | |
| 13G/A | Blue Owl Capital Holdings LP | 6.53 | 22.03 | |
| 13G | Goldman Sachs Group Inc | 7.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 298,344 | 1,004,126 | 29.71 | |
| 129,960 | 479,407 | 27.11 | |
| 152,160 | 410,201 | 37.09 | |
| 147,897 | 540,459 | 27.37 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KYMR – Kymera Therapeutics, Inc. | LGND – Ligand Pharmaceuticals Incorporated |
| LNTH – Lantheus Holdings, Inc. | LXEO – Lexeo Therapeutics, Inc. |
| MDWD – MediWound Ltd. |
Financial data and stock pages provided by
Fintel.io